Fulgent Genetics (FLGT) Other financing activities (2016 - 2026)

Fulgent Genetics has disclosed Other financing activities across 9 years of filings, most recently posting $4.2 million for Q1 2026.

• Other financing activities for Q1 2026 came in at $4.2 million, up 122.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.3 million (up 72.33% YoY), and the FY2025 annual result was $3.0 million, up 4.73% from the prior year.
• Other financing activities came in at $4.2 million for Q1 2026 at Fulgent Genetics, up from $447000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $4.2 million in Q1 2026 to a low of $232000.0 in Q2 2023.
• The 5-year median for Other financing activities is $494000.0 (2022), against an average of $860882.4.
• Peak annual rise in Other financing activities reached 1017.95% in 2022, while the deepest fall reached 92.38% in 2022.
• Fulgent Genetics' Other financing activities stood at $316000.0 in 2022, then jumped by 252.53% to $1.1 million in 2023, then slumped by 78.28% to $242000.0 in 2024, then jumped by 84.71% to $447000.0 in 2025, then surged by 839.6% to $4.2 million in 2026.
• The last three Other financing activities figures came in at $4.2 million (Q1 2026), $447000.0 (Q4 2025), and $357000.0 (Q3 2025), per Business Quant data.